Metoink 50 Tablet ER
Marketer
San-Pen Pharmaceuticals Private Limited
Salt Composition
Metoprolol Succinate (50mg)
Overview Metoink 50 Tablet ER
CardioBeta 50 Extended Release tablets are a beta-blocker medication indicated for managing hypertension, angina pectoris, and cardiac arrhythmias. This medication also contributes to migraine prevention and reduces the risk of future strokes and myocardial infarctions. CardioBeta 50 ER may be administered independently or in conjunction with other therapies, with dosage and frequency tailored to individual needs and condition severity. Administration can be with or without food, but consistent daily timing is crucial for optimal efficacy. Full therapeutic effects may take several weeks to manifest, and continued use, even in the absence of symptoms, is often necessary for long-term management. Discontinuation can exacerbate underlying conditions. Common, generally mild and transient, side effects include fatigue, cephalalgia, depressive symptoms, diarrhea, skin rash, bradycardia, dizziness, and nausea. Less frequent side effects include dyspnea and hypotension. Gradual dose escalation minimizes adverse reactions. Consult your physician regarding any persistent or bothersome side effects. Prior to initiating treatment, inform your doctor of any hepatic impairment. This medication may be contraindicated in individuals with bradycardia, severe circulatory compromise, decompensated heart failure, or hypotension. Pregnant or lactating individuals require medical consultation before use. A physician's assessment is crucial to determine suitability. Regular blood pressure monitoring ensures treatment effectiveness. Alcohol consumption should be avoided due to the potential for increased side effect incidence.
Uses of Metoink 50 Tablet ER
Managing angina pectoris (chest pain from heart issues) | Correcting cardiac arrhythmias | Reducing heart attack risk | Controlling hypertension (high blood pressure) | Preventing migraine headaches
Major Benefits of Metoink 50 Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Metoink 50 Tablet ER whole; do not crush, chew, or divide it. This medication can be taken with or without food, but consistent timing is recommended. High-fat foods, including olive oil, nuts (like Brazil nuts), dark chocolate, butter, and meat, should be avoided when taking Metoink 50 Tablet ER.
Common Side effects of Metoink 50 Tablet ER:
- Tiredness
- Dizziness
- Depression
- Breathlessness
- Headache
- Slow heart rate
- Nausea
- Rash
- Diarrhea
- Hypotension (low blood pressure)
How to use Metoink 50 Tablet ER:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Swallow the Metoink 50 Tablet ER whole; do not crush, chew, or break it. This medication can be taken with or without food, but consistent timing is recommended. For optimal absorption, minimize consumption of high-fat foods like olive oil, nuts (including Brazil nuts), dark chocolate, butter, and fatty meats.
How Metoink 50 Tablet ER works:
Extended-release Metoink 50mg tablets are a cardioselective beta-blocker, reducing heart rate and improving the heart's pumping efficiency for systemic circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Metoink 50 Tablet ER and alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
Extended-release Metoink 50mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Extended-release Metoink 50mg tablets are likely safe for breastfeeding mothers. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Extended-release Metoink 50mg tablets can cause drowsiness, blurred vision, and dizziness. Driving should be avoided if these effects are experienced.
KidneySAFE IF PRESCRIBED
Extended-release Metoink 50mg tablets are considered safe for use in individuals with impaired renal function. No alteration of the Metoink 50mg ER dosage is necessary.
LiverCAUTION
Patients with liver impairment should use Metoink 50 Extended-Release tablets cautiously. A modified Metoink 50 Extended-Release dosage might be necessary; physician consultation is advised.
What if you forget to take Metoink 50 Tablet ER :
Should you forget a Metoink 50 Tablet ER dose, take it immediately if you remember. But, if your next dose is nearly due, omit the missed dose and resume your usual dosing regimen. Never take a double dose.
Facts to Know About Metoink 50 Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Alcohols and Phenols |
| Developing Habits | No. |
| Treatment Category | HEART |





